title: Management of acute myocardial infarction in the elderly.
abstract: Thrombolysis and other new therapies have proved beneficial in elderly patients with myocardial infarction, but are underused in this age group. Because elderly patients are at greater cardiac risk than younger patients, they have more to gain from treatment. However, these treatments may pose more risk for elderly patients. Physicians must constantly assess the elderly patient's risk status and make treatment decisions based on risk-benefit analysis.
authors.affiliation: Department of Cardiology and Geriatrics/Gerontology, Medical College of Wisconsin, Milwaukee 53226, USA.
authors.forename: D D
authors.initials: DD
authors.lastname: Tresch
authors.forename: D
authors.initials: D
authors.lastname: Berkompas
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000368:Aged; D015906:Angioplasty, Balloon, Coronary; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D003131:Combined Modality Therapy; D001026:Coronary Artery Bypass; D006801:Humans; D008875:Middle Aged; D009203:Myocardial Infarction / Q000628:therapy*; D015912:Thrombolytic Therapy
chemical_list: D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants; D002121:Calcium Channel Blockers; D001241:Aspirin